About Disseminated Intravascular Coagulation
Key Highlights
-
Urgent, life-saving intervention for a critical blood disorder.Managed by specialized hematologists with expertise in complex coagulation.Focuses on treating the underlying cause while stabilizing the patient.Utilizes targeted blood product transfusions to restore clotting balance.Aims to prevent irreversible organ damage and fatal hemorrhage.
Who is this surgery for?
- Severe bacterial infections (sepsis) or viral infections.
- Major trauma, burns, or heatstroke.
- Complications during pregnancy (e.g., placental abruption, amniotic fluid embolism).
- Certain cancers, especially acute promyelocytic leukemia (APL).
- Severe liver disease or pancreatitis.
- Signs of abnormal bleeding alongside widespread clotting, such as oozing from IV sites, petechiae, or organ dysfunction.
How to prepare
- Immediate admission to an Intensive Care Unit (ICU) for continuous monitoring.
- Rapid collection of blood samples for coagulation profiles (PT, aPTT, fibrinogen, D-dimer), complete blood count, and peripheral smear.
- Securing large-bore intravenous (IV) access for fluid and blood product administration.
- Initiation of diagnostic workup to identify and treat the underlying trigger (e.g., imaging, cultures).
- Informing and counseling the patient's family about the critical nature of the condition.
Risks & possible complications
- Severe, uncontrollable hemorrhage leading to hypovolemic shock.
- Organ failure (kidney, liver, lungs) due to microvascular clots (thrombosis).
- Complications from massive blood product transfusions (e.g., transfusion reactions, fluid overload).
- Long-term complications like limb ischemia or necrosis from large vessel clots.
- High mortality rate, especially if diagnosis or treatment is delayed.
Recovery & hospital stay
- Initial recovery occurs in the ICU with close monitoring of vital signs, coagulation parameters, and organ function.
- As the underlying cause is treated and DIC resolves, blood product support is gradually tapered.
- Follow-up with the hematologist is essential to monitor for any recurrence or long-term effects.
- Recovery time depends heavily on the severity of the initial trigger and any organ damage sustained.
- Patients may require rehabilitation if organ damage (e.g., renal failure) or ischemic injuries occurred.
-
Typical hospital stay: 7-21 days (typically prolonged ICU stay)
-
Expected recovery time: Several weeks to months, depending on complications
Frequently Asked Questions
If you are considering disseminated intravascular coagulation in Turkey, these questions and answers can help you make a confident, informed decision.
Top-rated hospitals in Turkey with hematology departments and experienced surgeons are ideal for this procedure. Use MediFyr to compare facilities, reviews, and doctor profiles before you decide.
Look at the doctor’s years of experience, hospital association, patient reviews, and how often they perform disseminated intravascular coagulation. MediFyr helps you compare hematologists and book consultations online.
The overall cost depends on hospital category, surgeon’s experience, room type, implant or device used (if any), length of stay, tests, and post-operative care. Our team can help you get cost estimates from multiple hospitals before you decide.
Procedure cost in other countries
Here is an overview of how the estimated cost, hospital stay, and recovery time for disseminated intravascular coagulation compare across other countries where we have data.
| Country | Estimated cost range | Typical stay | Recovery time | View details |
|---|---|---|---|---|
| India | USD 1,652 – USD 5,506 | 7-21 days (typically prolonged ICU stay) | ~ Several weeks to months, depending on complications | Know More |
| Turkey | USD 12,293 – USD 40,978 | 7-21 days (typically prolonged ICU stay) | ~ Several weeks to months, depending on complications | Know More |
Ananya Patel, a 28-year-old software engineer...
Ananya Patel, a 28-year-old software engineer and new mother, was recovering from a difficult cesarean section when she began to feel unwell. Two weeks postpartum, she developed a high fever, severe abdominal pain, and noticed unusual bruising on her arms and legs. At the emergency room, she was found to have a severe uterine infection (septic endometritis) that had triggered a catastrophic condition called Disseminated Intravascular Coagulation (DIC). Her blood was clotting uncontrollably in her small vessels while simultaneously depleting her clotting factors, leading to dangerous bleeding from her surgical site and IV lines. Her hematologist, Dr. Chen, explained that DIC was a life-threatening complication of her infection. The immediate treatment involved aggressive intravenous antibiotics to fight the infection, transfusions of fresh frozen plasma and cryoprecipitate to replace her clotting factors, and platelets to stop the bleeding. Ananya spent five days in the ICU, terrified she wouldn't survive to care for her newborn daughter. The treatment was intense, involving multiple IV lines and constant monitoring. Gradually, as the infection was controlled, her blood tests stabilized. After a two-week hospital stay, she was discharged, weak but recovering. Emotionally, she transitioned from sheer terror and separation anxiety from her baby to profound gratitude and a fierce determination to heal. The experience left her with a deep appreciation for life and a cautious approach to her health as a new mother.
Hematologists for Disseminated Intravascular Coagulation
Explore experienced hematologists who regularly perform disseminated intravascular coagulation and provide pre- and post-operative care in Turkey.
- 22 Years Experience
- Hematologist
- 22 Years Experience
- Hematologist
- 22 Years Experience
- Hematologist
- 22 Years Experience
- Hematologist